|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.372 SEK | +0.54% |
|
-3.88% | -14.87% |
| Apr. 18 | Swedish Diagnostics Company AroCell Secures US Patent | MT |
| Feb. 22 | AroCell AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
AroCell AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 43.04 million compared to SEK 36.99 million a year ago. Net loss was SEK 59.3 million compared to SEK 58.97 million a year ago.
Basic loss per share from continuing operations was SEK 0.26 compared to SEK 0.28 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.87% | 7.82M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
AROCELL AB 
